Nifty

:

23587.50

Sensex

:

78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

Login

Nifty
Sensex

:
:

23587.50
78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

Unichem Laboratories Ltd.

Pharmaceuticals & Drugs - Global

Rating :

N/A

BSE: 506690 | NSE: UNICHEMLAB

Watchlist

NSE BSE

719.25

20-Dec-2024

Open
High
Low
Previous Close

752.10
754.95
710.50
745.45

Volume
Traded Value (lacs)
52 Week High
52 Week Low

30334
223.24
937.95
401.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

5,056.54
N/A
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

5,126.76
N/A
2.11

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

3.56
9.09
10.32

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-0.08
-
6.61

PAT CAGR (%)

10 Years
5 Years
3 Years

-
2.93
18.48

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

1.35
1.00
1.21

EV:EBITDA (Average)

8 Years
5 Years
3 Years

23.97
27.05
22.14

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS -13.09
P/E Ratio
Revenue 1393
EBITDA 51
Net Income -92
ROA -3.2
P/Bk Ratio 2.62
ROE -3.94
FCFF -27.5
FCFF Yield -0.45

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 436.88 333.83 30.87% 389.75 346.67 12.43% 399.24 310.06 28.76% 362.43 251.95 43.85%
Expenses 372.38 341.14 9.16% 349.55 338.36 3.31% 368.65 318.80 15.64% 343.11 294.11 16.66%
EBITDA 64.50 -7.31 - 40.20 8.31 383.75% 30.59 -8.73 - 19.32 -42.16 -
EBIDTM 14.76% -2.19% 10.31% 2.40% 7.66% -2.82% 5.33% -16.73%
Other Income 7.08 7.58 -6.60% 8.77 5.83 50.43% 7.04 3.79 85.75% 9.94 15.43 -35.58%
Interest 1.82 3.82 -52.36% 1.38 2.48 -44.35% 1.76 2.93 -39.93% 2.36 1.76 34.09%
Depreciation 26.39 27.26 -3.19% 26.11 27.36 -4.57% 25.22 28.32 -10.95% 25.62 28.64 -10.54%
PBT 43.37 -30.81 - 21.48 -15.70 - -114.97 -143.83 - 69.30 -57.12 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 43.37 -30.81 - 21.48 -15.70 - -114.97 -143.83 - 69.30 -57.12 -
PATM 9.93% -9.23% 5.51% -4.53% -28.80% -46.39% 19.12% -22.67%
EPS 6.16 -4.38 - 3.05 -2.23 - -16.33 -20.43 - 9.84 -8.11 -

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 462.16 415.63 11.20% 446.43 423.19 5.49% 431.70 402.10 7.36% 434.38 302.50 43.60%
Expenses 404.63 406.86 -0.55% 402.94 395.17 1.97% 406.35 385.62 5.38% 396.26 345.26 14.77%
EBITDA 57.53 8.77 555.99% 43.50 28.02 55.25% 25.35 16.48 53.82% 38.12 -42.76 -
EBIDTM 12.45% 2.11% 9.74% 6.62% 5.87% 4.10% 8.77% -14.14%
Other Income 8.79 5.53 58.95% 3.86 8.63 -55.27% 6.15 5.11 20.35% 11.28 16.35 -31.01%
Interest 4.79 6.73 -28.83% 4.03 5.76 -30.03% 4.59 5.52 -16.85% 5.58 4.09 36.43%
Depreciation 28.54 29.45 -3.09% 28.33 28.77 -1.53% 27.16 29.68 -8.49% 27.86 30.78 -9.49%
PBT 32.99 -21.88 - 15.00 2.12 607.55% -125.87 -47.16 - 83.97 -61.28 -
Tax 2.50 2.61 -4.21% 5.74 2.79 105.73% 3.44 -2.89 - -0.02 2.65 -
PAT 30.49 -24.49 - 9.25 -0.67 - -129.31 -44.27 - 83.99 -63.93 -
PATM 6.60% -5.89% 2.07% -0.16% -29.95% -11.01% 19.34% -21.13%
EPS 4.33 -3.48 - 1.31 -0.09 - -18.37 -6.29 - 11.93 -9.08 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 1,588.30 1,442.17 1,072.43 942.93 1,123.97 904.44 975.88 1,231.38 1,418.41 1,220.52 1,090.98 Net Sales Growth 27.83% 34.48% 13.73% -16.11% 24.27% -7.32% -20.75% -13.19% 16.21% 11.87% Cost Of Goods Sold 739.53 592.47 455.40 324.56 359.33 311.23 339.36 274.57 188.07 395.62 375.39 Gross Profit 848.77 849.69 617.03 618.37 764.64 593.21 636.52 956.81 1,230.34 824.90 715.59 GP Margin 53.44% 58.92% 57.54% 65.58% 68.03% 65.59% 65.23% 77.70% 86.74% 67.59% 65.59% Total Expenditure 1,433.69 1,391.25 1,165.35 986.48 1,028.51 995.05 1,034.20 1,214.03 1,252.60 1,078.24 989.74 Power & Fuel Cost - 105.64 101.41 77.12 67.95 72.14 75.43 48.26 40.76 37.34 38.36 % Of Sales - 7.33% 9.46% 8.18% 6.05% 7.98% 7.73% 3.92% 2.87% 3.06% 3.52% Employee Cost - 283.14 270.86 250.79 234.04 205.16 176.76 146.54 117.68 209.60 178.04 % Of Sales - 19.63% 25.26% 26.60% 20.82% 22.68% 18.11% 11.90% 8.30% 17.17% 16.32% Manufacturing Exp. - 222.94 189.07 189.10 207.65 139.62 136.04 115.50 90.53 132.41 129.61 % Of Sales - 15.46% 17.63% 20.05% 18.47% 15.44% 13.94% 9.38% 6.38% 10.85% 11.88% General & Admin Exp. - 93.26 88.02 82.51 94.82 196.55 200.15 566.05 722.03 145.52 132.64 % Of Sales - 6.47% 8.21% 8.75% 8.44% 21.73% 20.51% 45.97% 50.90% 11.92% 12.16% Selling & Distn. Exp. - 93.79 56.88 53.45 61.44 66.88 87.17 52.96 65.40 132.40 127.44 % Of Sales - 6.50% 5.30% 5.67% 5.47% 7.39% 8.93% 4.30% 4.61% 10.85% 11.68% Miscellaneous Exp. - 0.00 3.70 8.95 3.28 3.48 19.29 10.15 28.13 25.35 127.44 % Of Sales - 0% 0.35% 0.95% 0.29% 0.38% 1.98% 0.82% 1.98% 2.08% 0.76% EBITDA 154.61 50.92 -92.92 -43.55 95.46 -90.61 -58.32 17.35 165.81 142.28 101.24 EBITDA Margin 9.73% 3.53% -8.66% -4.62% 8.49% -10.02% -5.98% 1.41% 11.69% 11.66% 9.28% Other Income 32.83 30.39 41.85 42.07 47.37 99.17 101.54 3,280.20 7.19 22.71 20.31 Interest 7.32 10.42 9.38 2.07 1.30 1.28 0.62 3.17 2.00 2.29 2.37 Depreciation 103.34 105.46 105.98 83.19 75.89 71.09 61.71 45.04 39.41 34.99 37.68 PBT 19.18 -34.57 -166.43 -86.75 65.65 -63.81 -19.11 3,249.34 131.60 127.70 81.50 Tax 0.00 0.00 20.61 -31.32 11.56 -7.50 -27.91 692.74 27.73 23.69 17.10 Tax Rate 0.00% 0.00% -7.38% 36.10% 17.61% 11.75% 146.05% 21.32% 21.07% 19.08% 20.98% PAT 19.18 -92.18 -299.70 -55.43 54.08 -56.32 8.80 2,556.60 103.87 100.48 64.40 PAT before Minority Interest 19.18 -92.18 -299.70 -55.43 54.08 -56.32 8.80 2,556.60 103.87 100.48 64.40 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 1.21% -6.39% -27.95% -5.88% 4.81% -6.23% 0.90% 207.62% 7.32% 8.23% 5.90% PAT Growth 107.75% - - - - - -99.66% 2,361.35% 3.37% 56.02% EPS 2.72 -13.09 -42.57 -7.87 7.68 -8.00 1.25 363.15 14.75 14.27 9.15

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 1,774.67 1,704.89 1,343.02 1,269.83 1,235.14 1,103.71 1,188.19 1,379.90 1,540.06 1,332.65 1,201.79 Net Sales Growth 14.98% 26.94% 5.76% 2.81% 11.91% -7.11% -13.89% -10.40% 15.56% 10.89% Cost Of Goods Sold 668.43 565.63 482.45 356.91 302.14 308.63 364.19 274.97 188.77 386.97 378.57 Gross Profit 1,106.24 1,139.27 860.57 912.92 933.00 795.08 823.99 1,104.93 1,351.28 945.67 823.23 GP Margin 62.33% 66.82% 64.08% 71.89% 75.54% 72.04% 69.35% 80.07% 87.74% 70.96% 68.50% Total Expenditure 1,610.18 1,604.65 1,388.58 1,197.04 1,144.03 1,154.53 1,269.21 1,358.21 1,357.62 1,168.77 1,100.79 Power & Fuel Cost - 107.14 102.84 78.05 68.89 73.02 76.39 49.23 41.62 38.25 39.39 % Of Sales - 6.28% 7.66% 6.15% 5.58% 6.62% 6.43% 3.57% 2.70% 2.87% 3.28% Employee Cost - 393.06 356.41 330.49 306.97 273.28 238.52 200.64 169.04 255.92 223.20 % Of Sales - 23.05% 26.54% 26.03% 24.85% 24.76% 20.07% 14.54% 10.98% 19.20% 18.57% Manufacturing Exp. - 227.80 194.60 193.21 215.73 232.08 147.23 125.30 103.70 150.54 145.03 % Of Sales - 13.36% 14.49% 15.22% 17.47% 21.03% 12.39% 9.08% 6.73% 11.30% 12.07% General & Admin Exp. - 133.02 119.02 109.60 123.98 147.90 229.37 594.53 744.66 167.66 153.29 % Of Sales - 7.80% 8.86% 8.63% 10.04% 13.40% 19.30% 43.09% 48.35% 12.58% 12.76% Selling & Distn. Exp. - 178.00 129.56 120.68 122.52 116.12 197.24 108.38 107.77 166.84 157.12 % Of Sales - 10.44% 9.65% 9.50% 9.92% 10.52% 16.60% 7.85% 7.00% 12.52% 13.07% Miscellaneous Exp. - 0.00 3.70 8.11 3.81 3.50 16.26 5.16 2.06 2.58 157.12 % Of Sales - 0% 0.28% 0.64% 0.31% 0.32% 1.37% 0.37% 0.13% 0.19% 0.35% EBITDA 164.50 100.24 -45.56 72.79 91.11 -50.82 -81.02 21.69 182.44 163.88 101.00 EBITDA Margin 9.27% 5.88% -3.39% 5.73% 7.38% -4.60% -6.82% 1.57% 11.85% 12.30% 8.40% Other Income 30.08 31.60 38.52 47.51 50.19 91.31 98.41 3,278.19 5.50 19.11 20.72 Interest 18.99 22.66 17.31 6.11 5.12 7.85 7.52 8.01 3.36 2.90 3.04 Depreciation 111.89 113.24 113.44 91.17 84.36 81.67 67.37 50.51 43.52 38.79 41.27 PBT 6.09 -4.06 -137.80 23.03 51.82 -49.02 -57.50 3,241.36 141.07 141.31 77.41 Tax 11.66 8.81 25.86 -11.09 17.15 11.97 -33.64 696.23 32.58 29.30 2.13 Tax Rate 191.46% -14.29% -14.66% -48.15% 33.10% -24.42% 58.50% 21.48% 23.09% 21.27% 2.75% PAT -5.58 -70.47 -202.23 33.06 34.67 -61.00 -23.87 2,545.13 108.49 108.48 75.28 PAT before Minority Interest -5.58 -70.47 -202.23 33.06 34.67 -61.00 -23.87 2,545.13 108.49 108.48 75.28 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -0.31% -4.13% -15.06% 2.60% 2.81% -5.53% -2.01% 184.44% 7.04% 8.14% 6.26% PAT Growth 0.00% - - -4.64% - - - 2,245.96% 0.01% 44.10% EPS -0.79 -10.01 -28.73 4.70 4.92 -8.66 -3.39 361.52 15.41 15.41 10.69

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 2,294.63 2,384.27 2,672.04 2,697.33 2,647.18 2,731.93 2,761.67 1,130.73 1,027.15 947.42 Share Capital 14.08 14.08 14.08 14.08 14.08 14.08 14.07 18.18 18.17 18.15 Total Reserves 2,277.48 2,358.14 2,647.28 2,675.50 2,628.28 2,714.02 2,747.01 1,111.11 1,007.83 928.41 Non-Current Liabilities 81.13 113.21 139.63 50.27 29.68 26.79 50.07 70.40 63.66 69.27 Secured Loans 38.22 63.65 89.01 0.00 0.00 0.00 0.33 0.44 0.46 0.22 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 35.80 41.91 39.96 30.41 23.51 14.60 10.76 25.33 12.58 8.88 Current Liabilities 487.94 388.66 310.42 371.45 348.27 271.50 295.88 301.81 282.61 205.00 Trade Payables 249.49 244.47 157.08 188.57 208.22 192.69 211.51 228.28 189.63 142.63 Other Current Liabilities 102.60 119.82 125.82 168.06 115.02 67.56 60.40 56.73 47.43 36.32 Short Term Borrowings 0.00 12.36 11.43 0.00 15.21 0.00 0.00 0.55 7.90 0.00 Short Term Provisions 135.85 12.01 16.09 14.83 9.81 11.25 23.97 16.25 37.65 26.05 Total Liabilities 2,863.70 2,886.14 3,122.09 3,119.05 3,025.13 3,030.22 3,107.62 1,502.94 1,373.42 1,221.69 Net Block 1,164.94 1,235.94 963.12 846.23 824.94 785.16 551.12 464.17 381.20 395.87 Gross Block 1,718.31 1,690.90 1,323.61 1,128.33 1,037.52 939.38 655.08 535.64 414.65 683.53 Accumulated Depreciation 553.37 454.95 360.49 282.11 212.58 154.22 103.96 71.47 33.45 287.67 Non Current Assets 1,454.22 1,589.96 1,748.12 1,813.69 1,520.42 1,177.12 895.56 815.69 744.42 676.73 Capital Work in Progress 122.36 147.82 494.18 567.73 330.84 90.25 235.53 247.26 232.65 118.66 Non Current Investment 42.73 38.98 126.22 287.52 252.77 245.36 86.97 85.16 102.52 117.61 Long Term Loans & Adv. 124.18 167.22 164.61 112.21 111.88 56.36 21.94 19.11 28.05 44.59 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,406.13 1,292.76 1,370.49 1,305.37 1,504.71 1,853.10 2,212.05 687.25 629.00 544.95 Current Investments 1.34 1.54 263.58 236.43 419.10 800.75 895.55 8.00 8.04 35.04 Inventories 500.53 480.19 460.69 386.12 315.57 274.18 207.76 253.98 200.66 186.48 Sundry Debtors 558.42 472.08 380.84 360.48 323.10 331.35 231.74 296.49 264.73 206.19 Cash & Bank 129.06 157.28 99.03 57.59 205.37 191.03 673.61 10.16 10.94 19.71 Other Current Assets 216.79 25.93 29.99 57.62 241.57 255.79 203.40 118.61 144.63 97.52 Short Term Loans & Adv. 192.86 155.75 136.35 207.13 182.77 192.16 145.51 100.40 121.55 80.97 Net Current Assets 918.20 904.10 1,060.07 933.91 1,156.45 1,581.60 1,916.17 385.44 346.38 339.96 Total Assets 2,860.35 2,882.72 3,118.61 3,119.06 3,025.13 3,030.22 3,107.61 1,502.94 1,373.42 1,221.68

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 2,362.42 2,435.30 2,618.41 2,556.83 2,531.35 2,619.91 2,680.08 1,063.62 954.33 867.52 Share Capital 14.08 14.08 14.08 14.08 14.08 14.08 14.07 18.18 18.17 18.15 Total Reserves 2,345.27 2,409.18 2,593.65 2,535.00 2,512.44 2,601.99 2,665.42 1,044.00 935.01 848.52 Non-Current Liabilities 92.27 108.03 143.88 49.16 43.72 10.10 46.46 64.49 76.02 74.21 Secured Loans 38.22 63.65 89.01 0.00 0.00 0.00 0.33 0.44 22.98 20.35 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 35.80 41.91 39.96 30.41 23.51 14.60 10.76 25.33 12.58 8.88 Current Liabilities 707.88 639.60 552.13 505.76 566.73 502.92 463.51 392.62 275.09 211.76 Trade Payables 299.37 290.69 183.19 210.08 250.22 221.41 226.23 210.73 163.95 138.23 Other Current Liabilities 115.19 128.34 135.06 176.97 122.04 68.45 63.03 68.01 60.56 45.86 Short Term Borrowings 155.26 208.08 215.69 100.63 184.03 199.67 150.29 97.62 12.93 1.63 Short Term Provisions 138.06 12.50 18.19 18.09 10.44 13.39 23.97 16.25 37.65 26.05 Total Liabilities 3,162.57 3,182.93 3,314.42 3,111.75 3,141.80 3,132.93 3,190.05 1,520.73 1,305.44 1,153.49 Net Block 1,195.97 1,256.66 990.03 880.42 866.06 806.29 574.45 487.22 402.60 415.99 Gross Block 1,793.08 1,750.29 1,379.74 1,193.56 1,098.27 975.96 689.74 561.37 439.53 724.65 Accumulated Depreciation 597.10 493.63 389.70 313.14 232.21 169.67 115.29 74.15 36.92 308.66 Non Current Assets 1,465.06 1,591.06 1,666.02 1,734.44 1,455.33 1,093.64 853.59 772.27 673.34 589.07 Capital Work in Progress 122.71 147.45 493.81 567.50 330.47 92.39 238.15 249.98 237.13 122.64 Non Current Investment 0.02 0.16 0.28 159.12 134.38 129.20 9.20 9.51 5.54 5.83 Long Term Loans & Adv. 124.91 168.07 165.59 112.89 112.90 56.37 24.05 25.57 28.05 44.61 Other Non Current Assets 21.45 18.72 16.30 14.52 11.52 9.39 7.74 0.00 0.00 0.00 Current Assets 1,694.16 1,588.47 1,644.92 1,377.32 1,686.47 2,039.29 2,336.47 748.46 632.11 564.42 Current Investments 1.34 1.54 263.58 236.43 419.10 800.75 895.55 8.00 8.04 35.04 Inventories 704.68 625.23 600.22 538.34 396.54 338.66 272.86 281.71 230.57 207.68 Sundry Debtors 610.40 588.62 495.43 250.27 390.14 436.05 276.92 315.32 220.09 191.58 Cash & Bank 154.32 185.36 114.10 82.45 233.81 200.99 681.46 16.14 20.13 26.96 Other Current Assets 223.42 31.31 34.60 62.21 246.88 262.83 209.68 127.29 153.28 103.17 Short Term Loans & Adv. 194.09 156.40 136.99 207.62 183.04 194.18 145.51 98.80 122.77 82.25 Net Current Assets 986.28 948.86 1,092.80 871.56 1,119.74 1,536.37 1,872.95 355.84 357.02 352.66 Total Assets 3,159.22 3,179.53 3,310.94 3,111.76 3,141.80 3,132.93 3,190.06 1,520.73 1,305.45 1,153.49

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity -41.57 -117.33 -158.31 -32.61 -41.84 -251.30 -66.25 140.78 116.58 88.03 PBT -92.18 -279.09 -86.75 65.65 -63.81 -19.11 3,249.34 131.60 124.17 81.50 Adjustment 165.38 203.30 72.20 49.68 -6.17 -7.08 -3,214.36 72.37 56.10 36.30 Changes in Working Capital -114.62 -41.45 -147.82 -147.63 25.49 -217.91 -103.24 -35.89 -32.73 -11.59 Cash after chg. in Working capital -41.42 -117.24 -162.37 -32.30 -44.49 -244.10 -68.27 168.08 147.55 106.21 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.15 -0.09 4.06 -0.31 2.65 -7.20 2.01 -27.30 -30.97 -18.17 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 53.24 202.50 106.31 -80.39 -35.59 -322.63 1,648.30 -131.91 -86.73 -62.18 Net Fixed Assets -1.95 -20.93 -121.73 -327.70 -338.73 -139.02 -107.71 -135.60 154.89 -73.58 Net Investments -3.55 349.28 134.15 147.92 374.24 -63.59 -889.36 17.40 42.09 -32.73 Others 58.74 -125.85 93.89 99.39 -71.10 -120.02 2,645.37 -13.71 -283.71 44.13 Cash from Financing Activity -48.06 -61.76 95.80 -45.07 -21.02 -44.89 -929.51 -8.95 -38.63 -46.97 Net Cash Inflow / Outflow -36.39 23.41 43.81 -158.07 -98.45 -618.82 652.53 -0.08 -8.77 -21.12 Opening Cash & Equivalents 155.67 94.13 52.60 203.08 188.66 660.31 7.77 7.86 19.71 40.83 Closing Cash & Equivalent 125.65 155.67 94.13 52.60 203.08 188.66 660.31 7.77 10.94 19.71

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 16.69 -85.09 -259.61 32.98 19.82 -327.77 -112.34 68.19 111.91 78.10 PBT -61.67 -176.36 21.97 51.48 -48.21 -57.44 3,241.14 141.25 137.68 77.41 Adjustment 187.39 132.84 80.46 65.65 18.79 6.80 -3,207.66 53.31 39.65 35.57 Changes in Working Capital -102.65 -29.36 -354.43 -69.78 53.58 -264.94 -146.67 -98.65 -34.16 -16.49 Cash after chg. in Working capital 23.07 -72.88 -252.00 47.35 24.15 -315.57 -113.20 95.91 143.16 96.49 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -6.38 -12.21 -7.62 -14.36 -4.34 -12.20 0.86 -27.72 -31.25 -18.39 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 50.40 202.81 102.40 -73.56 -35.91 -286.01 1,648.33 -127.87 -85.33 -52.34 Net Fixed Assets -1.95 -20.93 -121.73 -327.70 -338.73 -139.02 -107.71 -135.60 154.89 -73.58 Net Investments -3.55 349.28 134.15 147.92 374.24 -63.59 -889.36 17.40 42.09 -32.73 Others 55.90 -125.54 89.98 106.22 -71.42 -83.40 2,645.40 -9.67 -282.31 53.97 Cash from Financing Activity -106.31 -81.30 191.23 -121.07 -62.30 -2.42 -881.13 59.23 -33.42 -50.95 Net Cash Inflow / Outflow -39.21 36.42 34.01 -161.65 -78.40 -616.19 654.86 -0.46 -6.84 -25.19 Opening Cash & Equivalents 183.75 109.20 77.46 231.52 197.05 666.07 11.21 11.67 26.96 52.15 Closing Cash & Equivalent 150.91 183.75 109.20 77.46 231.52 197.05 666.07 11.21 20.13 26.96

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 325.48 336.94 378.00 382.01 375.30 387.60 392.55 124.27 112.94 104.28 ROA -3.21% -9.98% -1.78% 1.76% -1.86% 0.29% 110.90% 7.22% 7.74% 5.30% ROE -3.95% -11.91% -2.07% 2.03% -2.10% 0.32% 131.43% 9.64% 10.19% 6.95% ROCE -3.38% -10.21% -3.08% 2.50% -2.32% -0.67% 167.06% 12.33% 12.75% 9.04% Fixed Asset Turnover 0.85 0.71 0.77 1.04 0.92 1.22 2.07 2.99 2.25 1.66 Receivable days 130.40 145.14 143.48 110.99 132.06 105.30 78.26 72.16 69.53 69.33 Inventory Days 124.11 160.11 163.90 113.93 119.00 90.13 68.41 58.46 57.16 61.90 Payable days 152.16 160.92 194.36 201.52 82.50 82.64 118.77 140.05 63.62 59.84 Cash Conversion Cycle 102.35 144.34 113.02 23.40 168.55 112.80 27.91 -9.43 63.06 71.39 Total Debt/Equity 0.03 0.04 0.05 0.00 0.01 0.00 0.00 0.00 0.01 0.00 Interest Cover -7.85 -28.75 -40.82 51.47 -48.78 -29.97 1027.03 66.88 55.19 35.41

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 335.11 344.18 370.38 362.05 358.85 371.69 380.95 116.88 104.93 95.48 ROA -2.22% -6.22% 1.03% 1.11% -1.94% -0.75% 108.06% 7.68% 8.82% 6.55% ROE -2.95% -8.04% 1.28% 1.37% -2.37% -0.90% 136.04% 10.77% 11.92% 8.95% ROCE -1.47% -5.60% 1.00% 2.12% -1.49% -1.77% 162.77% 13.42% 14.97% 9.29% Fixed Asset Turnover 0.96 0.86 0.99 1.08 1.06 1.43 2.21 3.08 2.32 1.71 Receivable days 128.35 147.31 107.17 94.63 136.61 109.51 78.30 63.41 55.72 58.55 Inventory Days 142.36 166.52 163.63 138.14 121.57 93.93 73.33 60.67 59.32 62.03 Payable days 190.38 179.25 201.09 278.03 76.39 73.41 94.97 104.25 52.00 52.61 Cash Conversion Cycle 80.33 134.58 69.71 -45.27 181.78 130.03 56.65 19.82 63.05 67.97 Total Debt/Equity 0.09 0.12 0.13 0.04 0.07 0.08 0.06 0.09 0.04 0.03 Interest Cover -1.72 -9.19 4.60 11.12 -5.25 -6.64 405.79 43.00 48.57 26.45

Top Investors:

hdfc small cap fund

investor education and protection fund authority ministry of corporate affairs

dsp healthcare fund

Annual Reports:

News Update:

Unichem Laboratories planning to consolidate generics formulations business in US market
23rd Sep 2024, 12:58 PM

The meeting of the Board of Directors of the Company scheduled to be held on September 30, 2024 to consider the same
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback